NCT00844675已完成4 期
Effects of Preoperative Administration of Oral Rabeprazole on the Prevention of Ulcer Bleeding Following Endoscopic Mucosal Resection(EMR): Prospective, Randomized, Placebo-controlled, Comparative Study
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 120
- 试验地点
- 1
- 主要终点
- Frequency of bleeding after EMR is performed
研究概览
简要总结
The purpose of this study is:
- To examine if oral administration of Pariet (proton pump inhibitor, 20mg tablets, twice daily for 5 days) before Endoscopic mucosal resection(EMR) exhibits preventive effects of ulcer bleeding compared with placebo group (preoperative administration of placebo)
- To evaluate the effects on the suppression of acid secretion of preoperative administration of an Proton pump inhibitor
详细描述
- Endoscopic mucosal resection (EMR) is less invasive than surgery and is known to be general treatment for early gastric cancer or gastric adenoma when patients' quality of life is taken into consideration. However, major complications such as bleeding and perforation remain to be problematic.1-5 The incidence of these complications is expected to rise as the size of lesions for which EMR is indicated has enlarged. Histamine 2 receptor antagonists (H2RA) and proton pump inhibitors (PPI) have been used for the bleeding,1-3 but the bleeding rate following EMR has been reported to be still high as 1.4% to 24%.1,4 Green et al and Berstad et al cited in their research that intragastric PH should be sustained above 5.4 to prevent bleeding, and PPIs should be administered instead of H2RAs to keep PH above 5.4. Being studied are administration modalities to enhance the therapeutic efficacy of PPIs or H2RAs.1-3 Several studies have already demonstrated that high-dose PPI therapy, for which a PPI was administered twice daily, effectively blocks acid secretion by increasing intragastric pH to neutral.3 Our study team also suggested in a previous study that high-dose PPI therapy was adequate to maintain intragastric pH above 6.
- PPIs are known to induce the suppression of acid secretion because they destroy a proton pump, yet it takes 5 days to achieve their maximum effects.7,8 It's been suggested that the onset of PPIs is slow to prevent bleeding with administration of a PPI after EMR.4 Therefore, our investigators expect that 5-day administration of an oral PPI before EMR would increase intragastric pH to above 6 and would be at least equal to or superior to intravenous PPIs currently being used in terms of the suppression of acid secretion.
- This is a prospective, randomized, comparative study to substantiate that oral administration of rabeprazole (Pariet tablets) 20mg twice daily before and after EMR (PO RBP group) will show similar effects on the prevention of bleeding compared with the conventional treatment with iv administration of pantoprazole after EMR but no special medication given before EMR (Placebo group). In addition, we are going to measure intragastric pH among part of study subjects and then to evaluate if the effect of acid suppression in the PO RBP group is superior to that in the placebo group.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Triple (Participant, Care Provider, Investigator)
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients who have EMR planned as well as meet the criteria described below will be selected as study subjects
- •Patients in whom EMR is indicated:
- •Gastric adenoma
- •Early gastric adenocarcinoma
- •Moderately or well differentiated adenocarcinoma
- •Gastric cancer limited to only mucosa on endoscopic ultrasonography
- •No invasion of lymph nodes or metastases (diagnosed by CT)
- •EMR to be performed for other diagnostic purposes
- •Women of child-bearing potential should avoid pregnancy
- •Subjects who consented to a EMR procedure in writing
排除标准
- •Patients who meet the criteria described below should be excluded from study subjects:
- •Younger than 18 years old
- •Patients with a history of upper gastrointestinal surgery or vagotomy
- •Patients with serious adverse reactions secondary to cardiac, renal, hepatic, or hematologic diseases (e.g. creatinine> 2.5 mg/dl, total bilirubin >3.0 mg/dl)
- •Patients with diseases that may have a great impact on the clinical study
- •Patients to whom the stimulation of gastrointestinal movement poses risks as in gastrointestinal bleeding, mechanical ileus and perforation
- •Women who are pregnant or nursing
- •Patients who are being treated with adrenocorticoid steroids, nonsteroidal anti-inflammatory drugs including aspirin, or other ulcer inducers
- •Patients who are taking other antiulcer drugs (antacids, antihistamines, etc) that may affect the efficacy assessments of the study drug (but, except for patients not taking the drugs over 7 days)
- •Patients with severe psychiatric diseases
- •Patients who received other investigational drugs within 30 days prior to the start of this study or who are currently participating in other clinical study
- •Patients who did not consent to the clinical study
- •Patients who can not be examined
- •Patients with bleeding tendency
- •Patients with esophageal varices
- •Patients with esophageal ulcer, stricture, or obstruction
- •Patients who have pacemaker or implantable cardiac defibrillator in place
研究组 & 干预措施
rabeprazole
Experimental
rabeprazole
干预措施: rabeprazole (Drug)
placebo
Experimental
placebo
干预措施: placebo (Drug)
结局指标
主要结局
Frequency of bleeding after EMR is performed
时间窗: 4weeks
次要结局
- Number (No./cm2) of visible vessels on the fundus of ulcer on endoscopy performed within 24 hours after EMR(day 1)
- Percentage of a pH change with intragastric pH greater than 6 in 24 hours after EMR(day 0)
- Measurement of a change in the size of ulcer(4weeks)
研究者
Myung-gui Choi
MD, PhD
The Catholic University of Korea
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Efficacy of Preoperative Administration of Paracetamol-codeine on Pain Following Impacted Mandibular Third Molar SurgeryTo Control Pain After Third Molar SurgeryNCT03049878University of Roma La Sapienza32
已完成
不适用
Adjuncts to general anesthetics in spine surgeryPACTR201710002416280Faculty of Medicine96
已完成
4 期
Analgesic Preoperative/Postoperative Dexketoprofen Trometamol in Third Molar SurgeryPostoperative PainNCT02380001Daniel Chavarría Bolaños60
已完成
4 期
Oral Glucocorticoids Effect on Post Endodontic PainPulpitisNCT02819648Cairo University400
已完成
4 期
Administration of Pre-Operative Gabapentin to Patients Undergoing LaparoscopyPostoperative PainNCT02359110Milton S. Hershey Medical Center112